Amphastar Pharmaceuticals AMPH Total Operating Expenses
Total Operating Expenses at other companies
Other financials
Where this comes from
Reported directly by Amphastar Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:OperatingExpenses.
The official record: Amphastar Pharmaceuticals’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Amphastar Pharmaceuticals's total operating expenses.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Amphastar Pharmaceuticals's total operating expenses?
- Amphastar Pharmaceuticals (AMPH) reported total operating expenses of $56.69M in Q1 2026.
- How has Amphastar Pharmaceuticals's total operating expenses changed year-over-year?
- Amphastar Pharmaceuticals's total operating expenses increased by 18.2% year-over-year, from $47.96M to $56.69M.
- What is the long-term trend for Amphastar Pharmaceuticals's total operating expenses?
- Over 4 years (2021 to 2025), Amphastar Pharmaceuticals's total operating expenses has grown at a 13.5% compound annual growth rate (CAGR), from $129.85M to $215.65M.
- What does total operating expenses mean?
- The sum of all operating costs including COGS, SG&A, R&D, D&A, and other operating charges. Revenue minus total operating expenses equals operating income.